Article
Does Good News About Biogen's Alzheimer's Drug Mean Bad News for Rivals? | The Motley Fool
Rating:
0.0
Views:
93
Likes:
1
Library:
1
Biogen's Alzheimer's disease drug, aducanumab, got positive news from the FDA last week. If the drug is approved, what does that mean for other companies with prospective Alzheimer's drug candidates?
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value